Characteristics | Active RA (n = 20) | Inactive RA (n = 24) | HCs (n = 20) | P value |
---|---|---|---|---|
Age (years)a | 46 (38–57) | 47 (40–53) | 48 (39–55) | > 0.05 |
Female (n (%)) | 16 (80.0) | 18 (75.0) | 15 (75.0) | > 0.05 |
Symptom duration (months)a | 10 (5–60) | 15 (8–70) | ND | 0.015b |
Swollen joint count (out of 28)a | 5 (3–8) | 2 (1–5) | ND | 0.039b |
Tender joint count (out of 28)a | 6 (2–9) | 4 (1–7) | ND | 0.027b |
CRP (mg/L)a | 6.5 (2.1–13.8) | 4.0 (1.4–9.2) | ND | 0.031b |
DAS28-CRP (3)a | 4.2 (3.5–5.6) | 1.8 (1.0–2.8) | ND | 0.001b |
ACPA (IU/ml)a | 451.9 (222.2–1208.0) | 129.6 (6.0–322.6) | ND | 0.006b |
RF (IU/ml)a | 132.0 (30.73–267.3) | 23.8 (19.0–75.1) | ND | 0.027b |
ACPA ≥ 17 IU/ml (n (%)) | 18 (90.0) | 17 (70.8) | ND | > 0.05b |
RF ≥ 20 IU/ml (n (%)) | 15 (75.0) | 17 (70.8) | ND | > 0.05b |
ACPA ≥ 17 IU/ml + RF ≥ 20 IU/ml (n (%)) | 14 (70.0) | 16 (66.7) | ND | > 0.05b |
ACPA ≤ 17 IU/ml + RF ≤ 20 IU/ml (n (%)) | 3 (15.0) | 4 (16.7) | ND | > 0.05b |